Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2025-12-30 @ 6:34 AM
Study NCT ID:
NCT00803166
Status:
COMPLETED
Last Update Posted:
2021-10-18
First Post:
2008-12-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams
Sponsor:
Padagis LLC
Organization:
Study Overview
Official Title:
Bioequivalence of Three Halobetasol Propionate 0.05% Topical Creams
Status:
COMPLETED
Status Verified Date:
2021-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study was to compare the relative vasoconstrictive effects of two test and one reference Halobetasol Propionate 0.05% Cream in healthy, female subjects.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: